Table 1.
Study | Number of patients |
---|---|
Devinsky et al. (22) - TRE OL | 214 |
Hess et al. (23) - Tuberous sclerosis OL | 18 |
Devinsky et al. (24) - Dravet RCT | 61 |
Thiele et al. (26) - LG RCT | 86 |
Devinsky et al. (25) - LG RCT 20 mg/kg | 76 |
Thiele et al. (30) - LG OL | 366 |
Devinsky et al. (31) - Dravet OL | 264 |
Szaflarski et al. (32) - TRE OL | 607 |
TRE, treatment-resistant epilepsy; OL, open label; LG, Lennox-Gastaut; RCT, randomized controlled trial.